Gainers
Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.
Gainers
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Third Quarter 2022 Operational Highlights
Total Gross Merchandise Volume ("GMV")6 was RMB18,632.1 million, an increase of 15.9% year-over-year.
Distribution GMV7 was RMB559.0 million, a decrease of 28.8%